Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease.

MLA

Dana, Jérémy, et al. “Conventional and Artificial Intelligence-Based Imaging for Biomarker Discovery in Chronic Liver Disease.” Hepatology International, vol. 16, no. 3, June 2022, pp. 509–22. EBSCOhost, https://doi.org/10.1007/s12072-022-10303-0.

APA

Dana, J., Venkatasamy, A., Saviano, A., Lupberger, J., Hoshida, Y., Vilgrain, V., Nahon, P., Reinhold, C., Gallix, B., & Baumert, T. F. (2022). Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatology International, 16(3), 509–522. https://doi.org/10.1007/s12072-022-10303-0

Chicago

Dana, Jérémy, Aïna Venkatasamy, Antonio Saviano, Joachim Lupberger, Yujin Hoshida, Valérie Vilgrain, Pierre Nahon, Caroline Reinhold, Benoit Gallix, and Thomas F Baumert. 2022. “Conventional and Artificial Intelligence-Based Imaging for Biomarker Discovery in Chronic Liver Disease.” Hepatology International 16 (3): 509–22. doi:10.1007/s12072-022-10303-0.